iRhythm Holdings

iRhythm Holdings

Health Care Equipment & Supplies
iRhythm Technologies Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

$3.6B

Market Cap • 9/18/2026

2006

(20 years)

Founded

2016

(10 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

19,4

P/S

4,4

P/EBITDA

P/OCF

41,9

P/FCF

92,5

P/E

BVPS

5,7

EPS

Market Cap

Market Cap

3,6B

EV

3,7B

EV/Revenue

4,5

EV/EBITDA

-894,9

EV/EBIT

-150,4

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-0,2%

Total Yield

-0,2%

Payout

0%

Retained Earnings

-817,8M

Profitability

Gross Margin

71,5%

EBITDA Margin

EBIT Margin

Net Margin

D&A/EBITDA

0%

R&D/Revenue

10,3%

Capex/Revenue

5,7%

Capex/D&A

227,3%

Capex/OCF

54,7%

SBC/OCF

97,3%

% PPE

18,7%

% Goodwill

0,1%

ROE

ROIC

Growth

CAGR Revenue 5Y

21,9%

CAGR Op. Income 5Y

-15,8%

CAGR Net Income 5Y

-25,2%

CAGR EPS 5Y

-26,8%

Leverage

N.D./EBITDA

Debt/Equity

0%

Current Ratio

3,9

Quick Ratio

3,4

Interest Coverage

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium